In this data article we describe synthetic and characterisation data for four members of the 5-acyl-6,7-dihydrothieno[3,2-c]pyridine (termed "RU-SKI") class of inhibitors of Hedgehog acyltransferase, including associated NMR spectra for final compounds. RU-SKI compounds were selected for synthesis based on their published high potencies against the enzyme target. RU-SKI 41 (9a), RU-SKI 43 (9b), RU-SKI 101 (9c), and RU-SKI 201 (9d) were profiled for activity in the related article "Click chemistry armed enzyme linked immunosorbent assay to measure palmitoylation by Hedgehog acyltransferase" [1].
Specification table

Subject area
Chemistry More specific subject area
Organic Synthesis
Type of data Synthetic scheme, experimental procedures, physical data, NMR spectra How data was acquired NMR (Bruker AM-400 or AM-500). High resolution mass spectrometry (AUTOSPEC P673 spectrometer). Microwave reactions (Biotage Initiator) Data format Analysed Experimental factors
N/A
Experimental features
Synthesis performed using standard organic chemistry techniques without inert atmosphere, unless otherwise stated.
Data source location N/A Data accessibility
Data are available in this article
Value of the data
Validated synthetic route to substituted 5-acyl-6,7-dihydrothieno[3,2-c]pyridines. The synthesised compounds can be used as inhibitors of Hedgehog acyltransferase (Hhat), termed "RU-SKI" inhibitors.
Synthetic data provides route for development of other Hhat inhibitors based on this molecular core with improved activity profiles.
NMR spectral data demonstrate biologically active RU-SKI compounds possess variable amide conformational preferences, which can be modulated.
Data
This article describes the synthesis and characterisation of four 5-acyl-6,7-dihydrothieno[3,2-c] pyridine ("RU-SKI") inhibitors of Hedgehog acyltransferase (Hhat) which were employed in doseresponse analysis in the related article "Click-chemistry armed enzyme linked immunosorbent assay to measure palmitoylation by Hedgehog acyltransferase" [1] . The RU-SKI inhibitors were identified and developed by Resh and co-workers [2, 3] , and the compounds with the highest published potencies against Hhat were selected for synthesis. RU-SKI 41 (9a), RU-SKI 43 (9b), RU-SKI 101 (9c) and RU-SKI 201 (9d) were synthesised according to our previously reported synthetic strategy to access the 5-acyl-6,7-dihydrothieno[3,2-c]pyridine core scaffold [4] . Inhibitors were analysed in our Click Chemistry Armed Enzyme Linked Immunosorbent Assay, displaying low-and sub-micromolar IC 50 values against Hhat [1] .
As demonstrated in our previous study of the 5-acyl-6,7-dihydrothieno[3,2-c]pyridine core [4] , the amide in the RU-SKI compounds also adopts two conformations (Fig. 1) . The conformational preference is affected by non-covalent interactions between the amide carbonyl and neighbouring substituents [4] . Altered conformational ratios are observed in the 1 H NMR data of the RU-SKI compounds (Table 1, Figs. 2,6 ,10 and 14). The synthetic, characterisation and conformational data of compounds 9a-9d is reported here, along with NMR spectra of final RU-SKI inhibitors.
Experimental design, materials and methods
Materials
Materials and equipment were as previously described [4] .
Abbreviations
EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), PyBOP ((benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate), TEA (triethylamine), DIPEA (N,N-diisopropylethylamine), DMF (dimethylformamide), DCM (dichloromethane), HOBt (hydroxybenzotriazole), TFA (trifluoroacetic acid), chex (cyclohexane).
General procedures
Synthesis of RU-SKI 41, 43, 101 and 201 followed our previously reported synthetic strategy (Scheme 1) [4] .
General procedure A (ethyl phenoxy acetate preparation)
2-Bromoethylacetate (0.66 mL, 5.99 mmol, 1 eq) was added dropwise to a solution of K 2 CO 3 (1660 mg, 12.0 mmol, 2 eq) and phenol (5.99 mmol, 1 eq) in acetone (25 mL) and stirred at room temperature overnight. The reaction mixture was concentrated in vacuo then dissolved in brine and extracted with ethyl acetate. The combined organic layers were dried over Na 2 SO 4 and the solvent removed in vacuo. The phenyl ether was used without further purification. Phenoxyethyl acetate (3.91 mmol, 1 eq) was dissolved in methanol (20 mL), and sodium methoxide solution (0.5 M, 2.12 mL, 19.5 mmol, 5 eq) added dropwise to the reaction mixture. 2-(3-Thienyl)ethylamine (0.47 mL, 508 mg, 3.91 mmol, 1 eq) was added dropwise and stirred overnight at room temperature. The solvent was removed in vacuo and the resulting crude material was dissolved in brine, extracted with ethyl acetate and the combined organic layers washed with water. The organic layer was dried over Na 2 SO 4 , concentrated in vacuo and the crude residue purified by flash column chromatography.
General procedures C, D, E, F, and N
General procedures C, D, E, F, and N were performed as previously described [4] .
General procedure G
General procedure G was performed as previously described [5] .
General procedure H
General procedure G was performed as previously described [6] .
2.3.6. General procedure I (ester hydrolysis of ethyl aminoacetate/preparation of ethyl amino acetic acid) Boc-protected ethyl aminoacetate (0.15 mmol, 1 eq) was dissolved in THF (5 mL), lithium hydroxide (1 M solution, 0.4 mL, 0.40 mmol, 3.8 eq) added and the reaction stirred overnight at room temperature. If necessary, more lithium hydroxide was added to the reaction mixture in order to drive the reaction to completion. The reaction was acidified with concentrated hydrochloric acid (pH 2) and extracted in ethyl acetate. The combined organic layers were dried over Na 2 SO 4 , concentrated in vacuo, and purified by column chromatography or used without further purification.
2.3.7. General procedure J (coupling of the side chain using PyBOP) (RU-SKI 41/43)
The amine obtained from general procedure F (0.11 mmol, 1 eq) was added to a solution of the acid obtained from general procedure I (0.12 mmol, 1.1 eq), DIPEA (52 μL, 0.30 mmol, 2.75 eq) and PyBOP (56 mg, 0.11 mmol, 1 eq) in DCM (5 mL) and the reaction stirred overnight at room temperature. The reaction was quenched by addition of water and extracted in ethyl acetate. The combined organic layers were washed with water and brine, dried over Na 2 SO 4, concentrated in vacuo, and purified by flash column chromatography.
General procedure K (coupling of the side chain using EDC/HOBt) (RU-SKI 101/201)
The amine obtained from general procedure F (0.043 mmol, 1 eq) and the Boc-protected acetic acid obtained from general procedure I (0.043 mmol, 1 eq) were dissolved in DMF ( $2 mL). HOBt (5.8 mg, 0.043 mmol, 1 eq), DIPEA (15 μL, 0.086 mmol, 2 eq) and EDC (12.4 mg, 0.065 mmol, 1.5 eq) were added to the reaction mixture and the reaction stirred overnight at room temperature. DCM was added and the solution washed with aqueous LiCl (5% w/w) and brine. The organic layer was dried over Na 2 SO 4 , concentrated in vacuo, and purified by flash column chromatography.
General procedure L (Boc deprotection by TFA)
The amide obtained from general procedure J or K (0.049 mmol, 1 eq) was dissolved in 1:1 mixture of DCM and TFA (5 mL). Afterwards, the solvent was removed in vacuo and the residual was neutralised by saturated sodium hydrogen carbonate, extracted with DCM three times and dried over MgSO 4 . The required amine was isolated using strong cation exchange resin and eluted with ammonia (2 M) in methanol to recover the free amine, and purified by flash column chromatography.
General procedure M (Boc deprotection by HCl in dioxane)
The amide obtained from general procedure J or K (0.18 mmol, 1 eq) was stirred in 4 M HClDioxane ($ 5 mL) for 2 h at room temperature. The solvent was removed in vacuo and the residue dissolved in ethyl acetate, washed with water and brine and dried over MgSO 4 . The required amine was isolated using strong cation exchange resin and eluted with ammonia (2 M) in methanol to recover the free amine, and purified by flash column chromatography.
General procedure N (coupling of the side chain using acid chlorides)
The amine obtained from general procedure F (0.09 mmol, 1 eq) and TEA (25 μL, 18 mg, 0.18 mmol, 2 eq) were dissolved in dry DCM (1 mL). The corresponding acid chloride (0.11 mmol, 1.2 eq) was added and the reaction mixture stirred at room temperature for 2 h. The solvent was removed in vacuo, and the residue purified by flash column chromatography. The ethyl (p-chlorophenoxy)acetate (1a) was obtained from 4-chlorophenol (0.59 mL, 770 mg, 5.99 mmol, 1 eq) and 2-bromoethylacetate (1 g, 5.99 mmol, 1 eq) using general procedure A as a white solid (1.28 g, 5.87 mmol, 98% 
RU-SKI synthetic data
The amide (2a) was obtained from 2-(3-thienyl)ethylamine (0.47 mL, 500 mg, 3.91 mmol, 1 eq) and ethyl (4-chlorophenoxy) acetate (850 mg, 3.91 mmol, 1 eq) using general procedure B as a white solid (975 mg, 3.30 mmol, 73% J¼8.7 Hz, 2 H). The amine (4a) was obtained from (4-chlorophenoxy)(1-thia-5-aza-6,7-dihydroinden-4-yl)methane (3a) (327mg, 1.18 mmol, 1 eq) using general procedure F as yellow oil (181 mg, 0.65 mmol, 55% 
Ethyl (allylamino)acetate (5a)
The ethyl aminoacetate (5a) was obtained from ethyl bromoacetate (0.66 mL, 1000 mg, 5.99 mmol, 1 eq) and allylamine (8.7 mL, 116.2 mmol, 19.4 eq) using general procedure G as a colourless oil (137 mg, 0.96 mmol, 15%). The crude material was used without further purification. 
(N-Allyl-N-tert-butoxycarbonylamino)acetic acid (7a)
The Boc protected aminoacetic acid (7a) was obtained from ethyl (N-allyl-N-tert-butoxycarbonylamino)acetate (6a) (37 mg, 0.15 mmol, 1 eq) using general procedure I as colourless oil (32 mg, 0.15 mmol, 97% 
N-Allyl(2-{4-[(p-chlorophenoxy)methyl]-1-thia-5-aza-4,5,6,7-tetrahydroinden-5-yl}-2-oxoethyl) amino 2,2-dimethylpropionate(8a)
The amide (8a) was obtained from (4-chlorophenoxy)(1-thia-5-aza-4,5,6,7-tetrahydroinden-4-yl) methane (4a) (82 mg, 0.29 mmol, 1 eq) and (N-allyl-N-tert-butoxycarbonylamino)acetic acid (7a) (69 mg, 0.32 mmol, 1.1 eq) using general procedure J as yellow oil (93 mg, 0.19 mmol, 67% 
1-[2-(2-Thienyl)ethylamino]-2-(m-tolyloxy)-1-ethanone (2b)
The amide (2b) was obtained from 2-(3-thienyl)ethylamine (0.48 mL, 522 mg, 4.08 mmol, 1 eq) and ethyl (m-tolyloxy)acetate (793 mg, 4.08 mmol, 1 eq) using general procedure B as a white solid (853 mg, 3.10 mmol, 76%). (1-Thia-5-aza-4,5,6,7-tetrahydroinden-4-yl)(m-tolyloxy)methane (4b) (ring closured imine 3b)/ (amine 4b)
The cyclic imine (1-thia-5-aza-6,7-dihydroinden-4-yl)(m-tolyloxy)methane (3b) was obtained from 1-[2-(2-thienyl)ethylamino]-2-(m-tolyloxy)-1-ethanone (2b) (807 mg, 2.93 mmol, 1 eq) using general procedure E as an orange oil (476 mg, 1.85 mmol, 63%). The crude material was used without further purification. 
Ethyl (2-methylbutylamino)acetate (5b)
The ethyl aminoacetate (5b) was obtained from ethyl bromoacetate (166 μL 250 mg, 1.50 mmol, 1 eq) and 2-methyl butylamine (3.3 mL, 2.53 g, 29.04 mmol, 1 eq) using general procedure G. The crude material was purified by Isolera (SiO 2 ; EtOAc:Hexane:TEA-12:88:1) and the expected compound was recovered as colourless oil (152 mg, 0.88 mmol, 58% The amide (8b) was obtained from (1-thia À 5-aza À 4,5,6,7-tetrahydroinden À 4-yl)(m-tolyloxy) methane (4b) (31 mg, 0.12 mmol, 1 eq) and (7b) [N-tert-butoxycarbonyl(2-methylbutyl)amino]acetic acid (32.3 mg, 0.13 mmol, 1.1 eq) using general procedure J as yellow oil (21 mg, 0.045 mmol, 37% The amine was synthesised as previously described [4] .
The amide (8c) was obtained from 4-(m-tolyl)-1-thia-5-aza-4,5,6,7-tetrahydroindene (4c) (28 mg, 0.12 mmol, 1 eq) and [N-tert-butoxycarbonyl(2-methylbutyl)amino]acetic acid (7b) (30 mg, 0.12 mmol, 1 eq) using general procedure K as a yellow oil (35 mg, 0.08 mmol, 64%). Rf 0.14 (SiO 2 ; EtOAc:Hex, 1:9). 
